CliffBio
small molecule

SODIUM SULFATE, MAGNESIUM SULFATE AND POTASSIUM CHLORIDE

MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM SULFATE

Loss of exclusivity—loss of exclusivity
CompanyLupin →See this company's full patent-cliff portfolio

Drug detail

Brand nameSODIUM SULFATE, MAGNESIUM SULFATE AND POTASSIUM CHLORIDE
Active ingredientMAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM SULFATE
Strength0.225GM;0.188GM;1.479GM
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalMay 2026
Marketing statusRX

More from Lupin

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.